Aligos Therapeutics (ALGS) Treasury Shares (2019 - 2021)

Aligos Therapeutics (ALGS) has reported Treasury Shares for 3 consecutive years, with $38.1 million the latest figure, recorded in Q1 2021.

• For the quarter ending Q1 2021, Treasury Shares rose 251.35% year-over-year to $38.1 million; the trailing twelve-month figure through Mar 2021 stood at $38.1 million (up 251.35% YoY), and the FY2019 full-year result was $10.8 million, changed N/A from the prior year.
• Treasury Shares climbed to $38.1 million in Q1 2021 per ALGS's latest filing, from $10.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $38.1 million in Q1 2021 and bottomed at $10.8 million in Q3 2019.
• Historically, Treasury Shares has averaged $15.4 million across 3 years, with a median of $10.9 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Treasury Shares advanced 0.47% in 2020, then soared 251.35% in 2021.
• Over 3 years, Treasury Shares stood at $10.8 million in 2019, then advanced by 0.35% to $10.9 million in 2020, then jumped by 251.35% to $38.1 million in 2021.
• According to Business Quant data, Treasury Shares over the past three periods registered $38.1 million, $10.9 million, and $10.9 million for Q1 2021, Q3 2020, and Q2 2020 respectively.